“…Up to now, only high performance liquid chromatography (HPLC)-based methods was exploited to analyze TGB, which suffers from drawbacks of being technically demanding, lack of sensitivity, and costly/time-consuming. , Fluorescence sensors have gained considerable attention in recent years for pharmaceutical analysis due to their operability, high sensitivity, and fast-speed. − In the pharmacokinetic studies, TGB has been discovered to bind with human serum albumin (HSA) through entering the hydrophobic cavity in Sudlow site II of HSA and forming specific cation-π bonds with the surrounding amino acids residues . Meanwhile, some HSA-based organic fluorescent probes, such as solvatochromic dyes, − twisted intramolecular charge transfer fluorophores, , and disassembly/aggregation induced emission based fluorophores, − were discovered displaying a fluorescence enhancement upon occupying the hydrophobic binding sites on of HSA. Inspired from site-specific occupying of HSA, some of fluorescent dyes have been facilely applied for probing binding sites of individual drug-based drug displacement reactions. − However, all of these assays demonstrates the principles of fluorescent “turn-off” mode.…”